Area of research
Hematology · Oncology
Research interest
Research interests include Acute Myeloid Leukemia Research, Hematopoietic Stem Cell Transplantation, CAR-T cell therapy research, and Myeloproliferative Neoplasms: Diagnosis and Treatment.
Acetyl-CoA carboxylase 1 inhibition increases Treg metabolism and graft-versus-host disease treatment efficacy via mitochondrial fusion
MaaT013 for ruxolitinib-refractory acute graft-versus-host disease with gastrointestinal involvement: Results from the ARES phase III trial
Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT
Novel prognostic scoring systems for severe CRS and ICANS after anti-CD19 CAR T cells in large B-cell lymphoma
CNS manifestations in acute and chronic graft-versus-host disease
Enforced gut homing of murine regulatory T cells reduces early graft-versus-host disease severity
A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma
Retinoic acid signaling acts as a rheostat to balance Treg function
Cutting Edge: TGF-β and Phosphatidylinositol 3-Kinase Signals Modulate Distinct Metabolism of Regulatory T Cell Subsets
The vimentin intermediate filament network restrains regulatory T cell suppression of graft-versus-host disease
Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production
Long-term outcomes of adults with first-relapsed/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA/SFGM-TC study